DWTX logo

DOGWOOD THERAPEUTICS INC

DWTXNASDAQ
πŸ† #3938 by market capEarnings Nov 4US Equity
$1.84β–² $0.00 (+0.27%)
Live
1hβ€”
24hβ–² 0.3%
7dβ–Ό 0.8%
14dβ–² 18.4%
30dβ–² 31.1%
1yβ–Ό 62.5%
🏦Market Cap
$62M
Small Cap
πŸ“ˆRevenue Growth (YoY)
β€”
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
β€”
Otter Score
50
Weak

Trading Snapshot

Day Range
$1.81 – $1.85
52-Week Range
$1.28 – $9.50
Volume
$5.51B
Avg Volume
$5.37B
Shares Outstanding
33.6M
Next Earnings
Sep 2, 2026

Fundamentals Snapshot

Annual Revenue
$6M
Last Q Revenue
$1M
P/E Ratio
β€”
P/S Ratio
β€”
EPS (TTM)
$-10.60
Dividend Yield
β€”

Why Investors Own DWTX

  • βœ“High-growth profile β€” revenue up +41.9% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 74% gross margin and 30% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$6Mβ–² +40.3% YoY
Gross Margin (TTM)
73.9%β–² +3.9% YoY
Operating Income (TTM)
$2Mβ–² +40.3% YoY
Free Cash Flow (TTM)
$2Mβ–² +40.3% YoY

About DOGWOOD THERAPEUTICS INC

A company profile for DOGWOOD THERAPEUTICS INC isn’t available yet β€” check back soon.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
50/100

Analyst Ratings

β“˜
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates